Belite Bio (BLTE) News Today

No Belite Bio (BLTE) headline in the last 7 days came with a measured price move.

Latest headline on this page:

1 headline on Belite Bio appeared in our news feed in the last 7 days with a measured price reaction attached.

What moved BLTE — last 7 days

Time Headline 1 min Reaction
Oct 14, 16:00:00 ET Belite Bio submits tinlarebant marketing applications through Access Consortium pathway for Stargardt disease in Singapore, United Kingdom and Switzerland +0.10% —

Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.

Related coverage

The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.